18 January is the deadline to respond to the European Commission’s 6 January proposal to amend the Medical Device Regulation by extending legacy product transition deadlines. This article explains how changes are expected to be made.
The European Commission is proposing introducing extended transition periods for legacy devices that fall under the scope of the Medical Device Regulation (MDR) and lengthening the transition period during which these legacy devices can be placed on the market.
This article explains how the MDR clauses will be changed. The sector has no time to lose until the...
Create an account to read this article
Already a subscriber?
The US FDA has authorized around 107 devices with Predetermined Change Control Plans in place, with PathAI's AISight Dx digital pathology image management system one of the latest. Medtech Insight talks to Eric Walk, chief medical officer, to find out about the process and its benefits.
Sean Keveney is largely unknown in the FDA law space, but likely is familiar and connected to the White House given his work on Trump’s antisemitism taskforce.
The US’ foreign trading partners are not working hard enough to secure bilateral deals, says US President Donald Trump, who will introduce new reciprocal tariffs on Aug. 7. MedTech Europe stresses that patients will suffer if medtech is not excluded from the tariffs.
